Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Validation of Independent Prognostic Value of Asphericity of 18F-Fluorodeoxyglucose Uptake in Non-Small-Cell Lung Cancer Patients Undergoing Treatment With Curative Intent.

Rogasch JMM, Furth C, Chibolela C, Hofheinz F, Ochsenreither S, Rückert JC, Neudecker J, Böhmer D, von Laffert M, Amthauer H, Frost N.

Clin Lung Cancer. 2019 Oct 15. pii: S1525-7304(19)30266-9. doi: 10.1016/j.cllc.2019.10.001. [Epub ahead of print]

PMID:
31839531
2.

Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options.

Jurmeister P, Vollbrecht C, Behnke A, Frost N, Arnold A, Treue D, Rückert JC, Neudecker J, Schweizer L, Klauschen F, Horst D, Hummel M, Dietel M, von Laffert M.

Lung Cancer. 2019 Dec;138:43-51. doi: 10.1016/j.lungcan.2019.10.005. Epub 2019 Oct 11.

PMID:
31634654
3.

Machine learning analysis of DNA methylation profiles distinguishes primary lung squamous cell carcinomas from head and neck metastases.

Jurmeister P, Bockmayr M, Seegerer P, Bockmayr T, Treue D, Montavon G, Vollbrecht C, Arnold A, Teichmann D, Bressem K, Schüller U, von Laffert M, Müller KR, Capper D, Klauschen F.

Sci Transl Med. 2019 Sep 11;11(509). pii: eaaw8513. doi: 10.1126/scitranslmed.aaw8513.

PMID:
31511427
4.

Immunohistochemical analysis of Bcl-2, nuclear S100A4, MITF and Ki67 for risk stratification of early-stage melanoma - A combined IHC score for melanoma risk stratification.

Jurmeister P, Bockmayr M, Treese C, Stein U, Lenze D, Jöhrens K, Friedling F, Dietel M, Klauschen F, Marsch W, Fiedler E, von Laffert M.

J Dtsch Dermatol Ges. 2019 Aug;17(8):800-808. doi: 10.1111/ddg.13917.

PMID:
31437373
5.

Immunhistochemische Analyse von Bcl-2, nukleärem S100A4, MITF und Ki67 zur Risikostratifizierung von Melanomen im Frühstadium - ein kombinierter immunhistochemischer Score.

Jurmeister P, Bockmayr M, Treese C, Stein U, Lenze D, Jöhrens K, Friedling F, Dietel M, Klauschen F, Marsch W, Fiedler E, von Laffert M.

J Dtsch Dermatol Ges. 2019 Aug;17(8):800-809. doi: 10.1111/ddg.13917_g. German.

PMID:
31437365
6.

Histomorphological and molecular profiling: friends not foes! Morpho-molecular analysis reveals agreement between histological and molecular profiling.

Hoberger M, von Laffert M, Heim D, Klauschen F.

Histopathology. 2019 Nov;75(5):694-703. doi: 10.1111/his.13930. Epub 2019 Sep 5.

PMID:
31152602
7.

Pilonidal sinus disease: an intergluteal localization of hidradenitis suppurativa/acne inversa: a cross-sectional study among 2465 patients.

Benhadou F, Van der Zee HH, Pascual JC, Rigopoulos D, Katoulis A, Liakou AI, Daxhelet M, Romanelli M, Iannone M, Kinyó Á, Nikolakis G, Zouboulis CC, Dessinioti C, Zisimou C, Antoniou C, Alavi A, Mintoff D, Aquilina S, Matusiak L, Szepietowski JC, Sinclair R, Husein-ElAhmed H, von Laffert M, Revuz J, Danby B, Puig L, Theut Riis P, Jemec GBE, van van Straalen K, Wigny KMGJ, Del Marmol V, Guillem P.

Br J Dermatol. 2019 Dec;181(6):1198-1206. doi: 10.1111/bjd.17927. Epub 2019 May 6.

PMID:
30919434
8.

DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancer.

Jurmeister P, Schöler A, Arnold A, Klauschen F, Lenze D, Hummel M, Schweizer L, Bläker H, Pfitzner BM, Mamlouk S, Sers C, Denkert C, Stichel D, Frost N, Horst D, von Laffert M, Capper D.

Mod Pathol. 2019 Jun;32(6):855-865. doi: 10.1038/s41379-019-0207-y. Epub 2019 Feb 5.

PMID:
30723296
9.

RNA-based analysis of ALK fusions in non-small cell lung cancer cases showing IHC/FISH discordance.

Vollbrecht C, Lenze D, Hummel M, Lehmann A, Moebs M, Frost N, Jurmeister P, Schweizer L, Kellner U, Dietel M, von Laffert M.

BMC Cancer. 2018 Nov 22;18(1):1158. doi: 10.1186/s12885-018-5070-6.

10.

ALK IHC and FISH discordant results in patients with NSCLC and treatment response: for discussion of the question-to treat or not to treat?

Cabillic F, Hofman P, Ilie M, Peled N, Hochmair M, Dietel M, Von Laffert M, Gosney JR, Lopez-Rios F, Erb G, Schalles U, Barlesi F.

ESMO Open. 2018 Sep 17;3(6):e000419. doi: 10.1136/esmoopen-2018-000419. eCollection 2018.

11.

Contrast-Enhanced Ultrasound (CEUS) and Quantitative Perfusion Analysis in Patients with Suspicion for Prostate Cancer.

Maxeiner A, Fischer T, Schwabe J, Baur ADJ, Stephan C, Peters R, Slowinski T, von Laffert M, Marticorena Garcia SR, Hamm B, Jung EM.

Ultraschall Med. 2019 Jun;40(3):340-348. doi: 10.1055/a-0594-2093. Epub 2018 Jun 6.

PMID:
29874683
12.

[Ichthyosis uteri (psoriasis uteri) : A very rare disorder].

von Laffert M, Elezkurtaj S, Sehouli J, Barinoff J, Boschetti Grützmacher E, Arsenic R, Bläker H.

Pathologe. 2018 May;39(3):264-268. doi: 10.1007/s00292-017-0403-9. German.

PMID:
29313082
14.

Increase of T and B cells and altered BACH2 expression patterns in bone marrow trephines of imatinib-treated patients with chronic myelogenous leukaemia.

Von Laffert M, Hänel M, Dietel M, Anagnostopoulos I, Jöhrens K.

Oncol Lett. 2016 Oct;12(4):2421-2428. Epub 2016 Aug 5.

15.

Recombinant HLA-G as Tolerogenic Immunomodulant in Experimental Small Bowel Transplantation.

von Websky MW, Kitamura K, Ludwig-Portugall I, Kurts C, von Laffert M, LeMaoult J, Carosella ED, Abu-Elmagd K, Kalff JC, Schäfer N.

PLoS One. 2016 Jul 12;11(7):e0158907. doi: 10.1371/journal.pone.0158907. eCollection 2016.

16.

[Statement of the German Society for Pathology and the working group thoracic oncology of the working group oncology/German Cancer Society on ALK testing in NSCLC: Immunohistochemistry and/or FISH?].

von Laffert M, Schirmacher P, Warth A, Weichert W, Büttner R, Huber RM, Wolf J, Griesinger F, Dietel M, Grohé C.

Pathologe. 2016 Mar;37(2):187-91. doi: 10.1007/s00292-016-0152-1. German. No abstract available.

PMID:
26984297
17.

[ALK-Diagnostics in NSCLC - Immunohistochemistry (IHC) and/or Fluorescence-in-situ Hybridisation (FISH)].

von Laffert M, Schirmacher P, Warth A, Weichert W, Büttner R, Huber RM, Wolf J, Griesinger F, Dietel M, Grohé Ch.

Pneumologie. 2016 Apr;70(4):277-81. doi: 10.1055/s-0042-102626. Epub 2016 Mar 16. German.

18.

Adult hemophagocytic lymphohistiocytosis causing multi organ dysfunction in a patient with multiple autoimmune disorders: when the immune system runs amok.

Fleischmann R, Böhmerle W, von Laffert M, Jöhrens K, Mengel A, Hotter B, Lindenberg R, Scheibe F, Köhnlein M, von Bahr Greenwood T, Henter JI, Meisel A.

Clin Case Rep. 2015 Dec 16;4(2):165-70. doi: 10.1002/ccr3.467. eCollection 2016 Feb.

19.

ALK-FISH borderline cases in non-small cell lung cancer: Implications for diagnostics and clinical decision making.

von Laffert M, Stenzinger A, Hummel M, Weichert W, Lenze D, Warth A, Penzel R, Herbst H, Kellner U, Jurmeister P, Schirmacher P, Dietel M, Klauschen F.

Lung Cancer. 2015 Dec;90(3):465-71. doi: 10.1016/j.lungcan.2015.09.022. Epub 2015 Oct 23.

PMID:
26547803
20.

Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group.

Dietel M, Bubendorf L, Dingemans AM, Dooms C, Elmberger G, García RC, Kerr KM, Lim E, López-Ríos F, Thunnissen E, Van Schil PE, von Laffert M.

Thorax. 2016 Feb;71(2):177-84. doi: 10.1136/thoraxjnl-2014-206677. Epub 2015 Nov 3. Review.

21.

Parallel screening for ALK, MET and ROS1 alterations in non-small cell lung cancer with implications for daily routine testing.

Jurmeister P, Lenze D, Berg E, Mende S, Schäper F, Kellner U, Herbst H, Sers C, Budczies J, Dietel M, Hummel M, von Laffert M.

Lung Cancer. 2015 Feb;87(2):122-9. doi: 10.1016/j.lungcan.2014.11.018. Epub 2014 Dec 6.

PMID:
25534130
22.

Multicenter immunohistochemical ALK-testing of non-small-cell lung cancer shows high concordance after harmonization of techniques and interpretation criteria.

von Laffert M, Warth A, Penzel R, Schirmacher P, Kerr KM, Elmberger G, Schildhaus HU, Büttner R, Lopez-Rios F, Reu S, Kirchner T, Pauwels P, Specht K, Drecoll E, Höfler H, Aust D, Baretton G, Bubendorf L, Stallmann S, Fisseler-Eckhoff A, Soltermann A, Tischler V, Moch H, Penault-Llorca F, Hager H, Schäper F, Lenze D, Hummel M, Dietel M.

J Thorac Oncol. 2014 Nov;9(11):1685-92. doi: 10.1097/JTO.0000000000000332.

23.

Multicenter ALK testing in non-small-cell lung cancer: results of a round robin test.

von Laffert M, Penzel R, Schirmacher P, Warth A, Lenze D, Hummel M, Dietel M.

J Thorac Oncol. 2014 Oct;9(10):1464-9. doi: 10.1097/JTO.0000000000000307.

24.

[Nasopharyngeal space-occupying lesion with middle ear effusion. Malignant or benign?].

von Laffert M, Arsenic R, Olze H, Dietel M, Uecker FC.

Pathologe. 2014 Jul;35(4):379-82. doi: 10.1007/s00292-013-1889-4. German.

PMID:
24401934
25.

Preliminary findings suggest hidradenitis suppurativa may be due to defective follicular support.

Danby FW, Jemec GB, Marsch WCh, von Laffert M.

Br J Dermatol. 2013 May;168(5):1034-9. doi: 10.1111/bjd.12233.

PMID:
23320858
26.

Morphology of pilonidal sinus disease: some evidence of its being a unilocalized type of hidradenitis suppurativa.

von Laffert M, Stadie V, Ulrich J, Marsch WC, Wohlrab J.

Dermatology. 2011;223(4):349-55. doi: 10.1159/000335373. Epub 2012 Jan 21.

PMID:
22269798
27.

Hidradenitis suppurativa/acne inversa: bilocated epithelial hyperplasia with very different sequelae.

von Laffert M, Stadie V, Wohlrab J, Marsch WC.

Br J Dermatol. 2011 Feb;164(2):367-71. doi: 10.1111/j.1365-2133.2010.10034.x. Epub 2010 Nov 23.

PMID:
20831631
28.

Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis.

von Laffert M, Helmbold P, Wohlrab J, Fiedler E, Stadie V, Marsch WC.

Exp Dermatol. 2010 Jun;19(6):533-7. doi: 10.1111/j.1600-0625.2009.00915.x. Epub 2009 Jul 29.

PMID:
19659829

Supplemental Content

Loading ...
Support Center